A consulting firm in the pharmaceutical and healthcare sectors with its own software solutions

The company is a recognized technology firm that has made a name for itself over the past quarter-century through the development, manufacture, and distribution of modular viscosity measurement systems and highly specialized medical software. With its innovative solutions and a strong foothold in the economically robust region of Rhineland-Palatinate, it offers a solid foundation for international trade and further growth. Its expertise and niche market positioning are clear indicators of the company’s sustainability and potential within its industry.

The company offers both services and consulting in the area of efficient, cost-optimized, and future-oriented data capture and digitization. The focus is on optimization, streamlining, and cost savings while maintaining high data quality (based on German standards). The company was founded more than 25 years ago and therefore possesses the necessary expertise. In addition to management, the company employs 8 staff members (4 full-time, 1 apprentice, 1 project staff member, 2 part-time workers). Depending on the workload, additional part-time workers are hired on a temporary basis as needed.

An established pharmaceutical company is opening up to new investors after existing minority shareholders expressed a desire to sell their shares. The company, which has been in business for over 40 years, is the European market leader in a specialized niche market with a near-monopoly position and wields impressive pricing power across large portions of its extensive product portfolio. The company develops, manufactures, and distributes approximately 700 high-quality products under GMP certifications from Swissmedic and the FDA (U.S.). In addition, the company offers services in the areas of documentation and contract manufacturing. A key USP lies in its unique international supplier network and first-class regulatory documentation, which is highly regarded worldwide. With a workforce of about 40 employees in Switzerland and another 10 abroad, the company exports its products to more than 50 countries. The domestic market, accounting for about 50% of sales, also contributes substantially to the company’s success. Thanks to strategic investments and measures already implemented, the company is on a growth trajectory and plans to double its revenue within the next five years—with a target EBITDA margin of at least 20%. The company plans to distribute 40% of net income before taxes as dividends in the future, increasing this to 50% later on. Initially, the return on invested capital is approximately 4% and is expected to rise to about 8% over the next five years in line with anticipated growth. A total of approximately 200 shares can be purchased at a price of CHF 6,000 each, which corresponds to about 16% of the share capital. Partial lots of 20 shares or more are also available for sale. This investment provides access to a profitable, established, and internationally active pharmaceutical company with a stable market position and attractive long-term return potential.

The company is an innovative player in the digital and IT sector, specializing in home care in Bavaria. With an established digital platform characterized by a unique selling proposition (USP), the company reaches over 40,000 users and maintains a strong market position through scalable processes and data-driven, customized offerings. Its ability to deliver products monthly and bill care insurance funds directly, combined with a robust team structure, contributes significantly to growth within the healthcare sector and generates revenue from multiple sources.

Overview: The company is a comprehensive provider of consulting and training services in the field of healthcare IT and has an extensive B2B network that connects hundreds of clinics with IT providers through events throughout the DACH region. Investment Highlights: Stable recurring revenue from membership fees paid by a large network of hospitals and IT providers. Long-term customer relationships without dependence on individual clients. A digital transformation incubator that optimizes the testing of new IT solutions in medical facilities. An annual competition where the best new digital solutions can be tested in hospitals throughout the DACH region. Startup events that bring together digital entrepreneurs and B2B clients in the healthcare sector. Growth Opportunities: Expansion of internal consulting and workshop capacities to reduce external service costs. Increased demand for IT services in the healthcare sector due to new guidelines on data security and AI. Targeted member acquisition for hospital IT and infrastructure services (requires additional staff). Strengthening relationships with existing U.S. partner hospitals to offer international networks. Continuous expansion of the range of certifications offered to meet industry requirements.